Myelocytic
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML (NCT00502385) | AstraZeneca | 2004-04-01 |
Track Myelocytic automatically
Every clearance here is in the API, with alerts when new ones post.